New strains of COVID-19 variants need extra protection

A new variant of COVID-19 virus is showing up, and is especially prevalent in the North Eastern region of the US. The variant known as XBB.1.5 has emerged as the dominant strain in that area, according to the Centers for Disease Control and Prevention, making up nearly half of new infections. The XBB.1.5 variant made […]
Top new treatments for Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic condition that already affects around 1.5 million Americans, and about 100,000 new cases are diagnosed each year. It is one of the more than 80 conditions known as autoimmune diseases, and ranks near the top for worldwide incidence, with more than 25 million people affected. The term “rheumatoid arthritis” […]
NY Times article about Indian pharma drug quality

On November 3rd, 2022, an article was published on the front page of the New York Times, reporting on an alarming incidence of prescription drug related deaths across several West African countries. In one single outbreak, 70 children in the tiny nation of Gambia are suspected to have died over recent months from a batch […]
Coming Soon – a vaccine medication targeting AIDS, some cancers and infections

A new study shows that people with AIDS might soon be able to be treated with just a single vaccine dose, which potentially acts as a unique new AIDS/HIV treatment. The early findings are coming from researchers at the Tel Aviv University (School of Neurobiology, Biochemistry & Biophysics and the Sackler Faculty of Medicine) in […]
Does Ofev increase life expectancy?

Idiopathic Pulmonary Fibrosis (often referred to as IPF) is a condition characterized by pulmonary hypertension, in which the lungs become scarred, and breathing becomes increasingly difficult. Patients develop a chronic, progressive and irreversible decline in lung function. The term ‘idiopathic’ indicates that there is no clear indication of what causes the scarring. IPF affects about […]
Newsweek Asks Why the FDA is Refusing to Allow Use of Nasal Sprays as a Barrier Against COVID-19

In an article published on Newsweek’s website on September 11th, they raise some of the same points about the value of Sanotize’s Enovid NONS nasal spray (also known as VirX) in fighting the COVID-19 pandemic that we have been writing about here for many months. The proven value of Enovid isn’t the only reason for […]
Worried About Local Vaccination Levels?

Look around you. Most TV commentators and other sources of information are looking at the “big picture” and so when they report on levels of immunization now achieving a “healthy” level of 50% of the overall population, there are some variances by state, and within states, that could be making a difference for your level […]
Vaccine Alternatives for Immunocompromised People

As the COVID-19 vaccine rollout gathers pace, a population is at risk of being left behind: the millions of immunocompromised people around the globe who lack fully functional immune systems. For them, vaccines may not be as effective, because they are less capable of making their own antibodies to neutralize the SARS-CoV-2 virus. Instead, pharmaceutical […]
Expanding the battle against COVID-19: Two New Nasal Sprays Keep You Defended

Countries like Israel and the UK poured all of their resources into getting their people vaccinated against COVID-19 as quickly as possible. But now, after the great success of the vaccines, there are emerging several levels of concern when administrators and scientists are seeing the effects of newer variants of the virus. This makes it […]
Battling COVID-19 with Enovid Nitric Oxide Nasal Spray (NONS)

The battle against viruses and infections goes into overdrive this week, with the release of the long-awaited Israeli-invented nasal spray that kills 99.99% of all viruses in 2 minutes. The over-the-counter spray called Enovid also known as VirX was developed by the joint Israel-Canada biotech startup SaNOtize established by Dr. Gilly Regev and Dr. Chris […]


